Jennifer is an experienced healthcare policy analyst, focusing on Medicare, Medicaid and commercial payment issues impacting the US healthcare industry.
Jennifer works with clients to understand the financial impact of health policies and regulations on their business objectives, and in particular, specializes in interpreting complex drug pricing models. She supports industry stakeholders, including providers, pharmaceutical, medical device and diagnostics companies, through in-depth and rapid turnaround research analyses on specific mechanisms within Medicare, Medicaid, and commercial payment models.
Prior to joining McDermottPlus, Jennifer held roles at the Center for Health Policy and Outcomes at Memorial Sloan Kettering Cancer Center and public policy centers of New York University and Bucknell University.
CMS Releases CY 2023 End-Stage Renal Disease Prospective Payment System Proposed Rule
President’s FY 2023 Budget: HHS Highlights
CMS Releases CY 2022 Physician Fee Schedule Final Rule
CMS Innovation Center Strategy Refresh: Policy Update
CMS Releases CY 2022 Physician Fee Schedule Proposed Rule
Leveraging Real World Data and Real World Evidence: How the FDA and ...
TPNIES – Leveraging Lessons Learned From NTAP
Health Policy Breakroom Ep. 61 - Welcome Aaron Badida and Jennifer Ohn!
Show MoreDo not send any information or documents that you want to have treated as secret or confidential. Providing information to McDermott via email links on this website or other introductory email communications will not create an attorney-client relationship; will not preclude McDermott from representing any other person or firm in any matter; and will not obligate McDermott to keep confidential the information you provide. McDermott cannot enter into an attorney-client relationship with you until McDermott has determined that doing so will not create a conflict of interest and until you and McDermott have entered into a written agreement or engagement letter that sets forth the terms of our relationship.